• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一氧化氮供体治疗骨质疏松症。

Nitric oxide donors for the treatment of osteoporosis.

机构信息

Multidisciplinary Osteoporosis Research Program, Women's College Hospital, 790 Bay Street, 7th Floor, Toronto, ON M5G 1N8, Canada.

出版信息

Curr Osteoporos Rep. 2012 Mar;10(1):86-92. doi: 10.1007/s11914-011-0087-7.

DOI:10.1007/s11914-011-0087-7
PMID:22210559
Abstract

The number of osteoporotic fractures is increasing worldwide as populations age. An inexpensive and widely available treatment is necessary to alleviate this increase in fractures. Current treatments decrease fractures at trabecular bone sites (spine) but have limited effects at cortical sites (hip, legs, forearm, and upper arm)-the most common sites of osteoporotic fracture. Treatments are also limited by costs, side effects, and lack of availability. Nitric oxide is a novel agent that has the potential to influence cortical bone, is inexpensive, is widely available, and has limited side effects. In this review we evaluate the in vitro and in vivo data which support the concept that nitric oxide is important in bone cell function, review the observational and case-control studies reporting on subjects taking organic nitrates that act as nitric oxide donors, and review the effects of nitrates on bone mineral density measurements and fracture risk.

摘要

随着人口老龄化,世界范围内骨质疏松性骨折的数量正在增加。需要一种廉价且广泛可用的治疗方法来减轻这种骨折的增加。目前的治疗方法可以减少在小梁骨部位(脊柱)的骨折,但对皮质骨部位(髋部、腿部、前臂和上臂)的骨折影响有限,而这些部位是骨质疏松性骨折最常见的部位。治疗方法还受到成本、副作用和供应不足的限制。一氧化氮是一种新型药物,具有影响皮质骨的潜力,价格低廉,广泛可用,副作用有限。在这篇综述中,我们评估了支持一氧化氮对骨细胞功能重要性的体外和体内数据,回顾了报告服用有机硝酸盐(作为一氧化氮供体)的受试者的观察性和病例对照研究,并回顾了硝酸盐对骨密度测量和骨折风险的影响。

相似文献

1
Nitric oxide donors for the treatment of osteoporosis.一氧化氮供体治疗骨质疏松症。
Curr Osteoporos Rep. 2012 Mar;10(1):86-92. doi: 10.1007/s11914-011-0087-7.
2
Organic nitrates for osteoporosis: an update.用于治疗骨质疏松症的有机硝酸盐:最新进展
Bonekey Rep. 2013 Feb 6;2:259. doi: 10.1038/bonekey.2012.259.
3
The effects of organic nitrates on osteoporosis: a systematic review.有机硝酸盐对骨质疏松症的影响:系统评价。
Osteoporos Int. 2013 Mar;24(3):763-70. doi: 10.1007/s00198-012-2262-9. Epub 2013 Jan 11.
4
Areal and volumetric bone mineral density and risk of multiple types of fracture in older men.老年男性的骨面积和骨体积密度与多种骨折类型的风险
Bone. 2016 Nov;92:100-106. doi: 10.1016/j.bone.2016.08.014. Epub 2016 Aug 20.
5
Role of nitric oxide in type 1 diabetes-induced osteoporosis.一氧化氮在 1 型糖尿病性骨质疏松症中的作用。
Biochem Pharmacol. 2022 Mar;197:114888. doi: 10.1016/j.bcp.2021.114888. Epub 2021 Dec 28.
6
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.安大略省双能X线吸收法骨密度测定的应用:基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.
7
Effects of denosumab on cortical and trabecular microarchitecture: evidences from clinical studies.地舒单抗对皮质骨和松质骨微观结构的影响:来自临床研究的证据。
Aging Clin Exp Res. 2013 Oct;25 Suppl 1:S19-22. doi: 10.1007/s40520-013-0086-x. Epub 2013 Sep 18.
8
Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.唑来膦酸静脉给药联合特立帕肽[rhPTH(1-34)]皮下注射治疗绝经后骨质疏松症的效果。
J Bone Miner Res. 2011 Mar;26(3):503-11. doi: 10.1002/jbmr.238.
9
The discriminative ability of peripheral and axial bone measurements to identify proximal femoral, vertebral, distal forearm and proximal humeral fractures: a case control study.外周和轴向骨测量对识别股骨近端、椎体、前臂远端和肱骨近端骨折的鉴别能力:一项病例对照研究。
Osteoporos Int. 2005 Dec;16(12):1794-802. doi: 10.1007/s00198-005-1931-3. Epub 2005 Jun 10.
10
A randomized clinical trial of the effects of isosorbide mononitrate on bone formation and resorption in post-menopausal women: a pilot study.单硝酸异山梨酯对绝经后女性骨形成和骨吸收影响的随机临床试验:一项初步研究。
Hum Reprod. 2006 May;21(5):1320-4. doi: 10.1093/humrep/dei487. Epub 2006 Jan 12.

引用本文的文献

1
Fluorescent small molecule donors.荧光小分子给体。
Chem Soc Rev. 2024 Jun 17;53(12):6345-6398. doi: 10.1039/d3cs00124e.
2
Alamandine attenuates ovariectomy-induced osteoporosis by promoting osteogenic differentiation via AMPK/eNOS axis.阿拉曼丁通过 AMPK/eNOS 轴促进成骨细胞分化来减轻卵巢切除诱导的骨质疏松症。
BMC Musculoskelet Disord. 2024 Jan 10;25(1):45. doi: 10.1186/s12891-023-07159-2.
3
Changes in Bone Marrow Fatty Acids Early after Ovariectomy-Induced Osteoporosis in Rats and Potential Functions.大鼠卵巢切除诱导骨质疏松后早期骨髓脂肪酸的变化及其潜在功能

本文引用的文献

1
Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial.硝酸甘油软膏对绝经后妇女骨密度和骨强度的影响:一项随机试验。
JAMA. 2011 Feb 23;305(8):800-7. doi: 10.1001/jama.2011.176.
2
Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.非典型转子下和骨干股骨骨折:美国骨矿研究学会工作组报告。
J Bone Miner Res. 2010 Nov;25(11):2267-94. doi: 10.1002/jbmr.253.
3
A longitudinal HR-pQCT study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover.
Metabolites. 2022 Dec 26;13(1):36. doi: 10.3390/metabo13010036.
4
Diabetoporosis: Role of nitric oxide.糖尿病性骨质疏松症:一氧化氮的作用
EXCLI J. 2021 Apr 16;20:764-780. doi: 10.17179/excli2021-3541. eCollection 2021.
5
Precision Redox: The Key for Antioxidant Pharmacology.精准氧化还原:抗氧化药理学的关键。
Antioxid Redox Signal. 2021 May 10;34(14):1069-1082. doi: 10.1089/ars.2020.8212. Epub 2020 Dec 2.
6
The effect of PDE5 inhibitors on bone and oxidative damage in ovariectomy-induced osteoporosis.磷酸二酯酶5抑制剂对去卵巢诱导的骨质疏松症中骨骼及氧化损伤的影响
Exp Biol Med (Maywood). 2017 May;242(10):1051-1061. doi: 10.1177/1535370217703352. Epub 2017 Apr 11.
7
The Protective and Therapeutic Effect of Exclusive and Combined Treatment with Alpha-ketoglutarate Sodium Salt and Ipriflavone on Bone Loss in Orchidectomized Rats.α-酮戊二酸钠盐与依普黄酮单独及联合治疗对去势大鼠骨质流失的保护和治疗作用
J Nutr Health Aging. 2016;20(6):628-36. doi: 10.1007/s12603-015-0654-1.
8
Soluble guanylate cyclase as a novel treatment target for osteoporosis.可溶性鸟苷酸环化酶作为骨质疏松症的新型治疗靶点。
Endocrinology. 2014 Dec;155(12):4720-30. doi: 10.1210/en.2014-1343. Epub 2014 Sep 4.
9
Nongenomic thyroid hormone signaling occurs through a plasma membrane-localized receptor.非基因组甲状腺激素信号传导通过定位在质膜上的受体发生。
Sci Signal. 2014 May 20;7(326):ra48. doi: 10.1126/scisignal.2004911.
10
The influence of disuse on bone microstructure and mechanics assessed by HR-pQCT.通过高分辨率外周定量CT评估废用对骨微结构和力学性能的影响。
Bone. 2014 Jun;63:132-40. doi: 10.1016/j.bone.2014.02.014. Epub 2014 Mar 3.
一项关于阿仑膦酸钠治疗绝经后低骨密度女性的纵向 HR-pQCT 研究:骨密度、皮质和小梁微结构、生物力学和骨转换之间的关系。
J Bone Miner Res. 2010 Dec;25(12):2558-71. doi: 10.1002/jbmr.157. Epub 2010 Jun 18.
4
Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis.绝经后骨质疏松症妇女接受特立帕肽治疗 18 个月后外周部位的小梁和皮质骨微观结构的变化。
Osteoporos Int. 2011 Jan;22(1):357-62. doi: 10.1007/s00198-010-1226-1. Epub 2010 May 11.
5
Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate.皮质骨和松质骨的微观结构恶化:地舒单抗和阿仑膦酸钠的不同作用。
J Bone Miner Res. 2010 Aug;25(8):1886-94. doi: 10.1002/jbmr.81.
6
Use of organic nitrates and the risk of hip fracture: a population-based case-control study.使用有机硝酸盐与髋部骨折风险:基于人群的病例对照研究。
J Clin Endocrinol Metab. 2010 Apr;95(4):1924-31. doi: 10.1210/jc.2009-2342. Epub 2010 Feb 3.
7
Denosumab for prevention of fractures in postmenopausal women with osteoporosis.地诺单抗预防绝经后骨质疏松症女性骨折
N Engl J Med. 2009 Aug 20;361(8):756-65. doi: 10.1056/NEJMoa0809493. Epub 2009 Aug 11.
8
Transdermal nitroglycerin therapy may not prevent early postmenopausal bone loss.经皮硝酸甘油治疗可能无法预防绝经后早期骨质流失。
J Clin Endocrinol Metab. 2009 Sep;94(9):3356-64. doi: 10.1210/jc.2008-2225. Epub 2009 Jun 23.
9
Proximal femoral structure and the prediction of hip fracture in men: a large prospective study using QCT.股骨近端结构与男性髋部骨折的预测:一项使用定量CT的大型前瞻性研究
J Bone Miner Res. 2008 Aug;23(8):1326-33. doi: 10.1359/jbmr.080316.
10
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.每年一次唑来膦酸用于治疗绝经后骨质疏松症。
N Engl J Med. 2007 May 3;356(18):1809-22. doi: 10.1056/NEJMoa067312.